EUCTR2005-001658-25-BE进行中（未招募）不适用
An open label, two period crossover study to explore the safety, pharmacokinetics and pharmacodynamics of PHA-794428 after single subcutaneous injections in adult male patients with growth hormone deficiency.
Pfizer Global Research and Development0 个研究点目标入组 8 人开始时间: 2005年7月5日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 8
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •Adult male patients with severe GHD aged 25 to 60 years.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Subjects who on direct questioning and physical examination have evidence of any clinically significant disease other than hypopituitarism. Hypopituitary patients must be on adequate hormone replacement therapy.
研究者
相似试验
已完成
不适用
A study of two different formulations of buprenorphine in healthy volunteers.PainAddictionACTRN12617000002381iX Biopharma Pty Ltd14
招募中
不适用
Effect of chi 4 pendant and Digital Clock on EEGCTRI/2023/01/048984Contrive Techstar Pvt Ltd
进行中（未招募）
不适用
An open-label, randomized 2-period crossover study to investigate the pharmacodynamics, pharmacokinetics, safety and tolerability of warfarin in combination with oseltamivir in volunteers stabilized on warfarin therapy.EUCTR2007-005037-11-GBF.Hoffmann-La Roche Ltd
进行中（未招募）
1 期
An open label, randomized 2 part crossover study to investigate the effect of buprenorphine transdermal delivery system (BTDS) compared with co-codamol on physical activity in subjects aged 60 years or over with knee pain secondary to osteoarthritis. - Effect of BTDS on physical activity in elderly subjects with knee pain secondary osteoarthritisOsteoarthritis of the kneeMedDRA version: 9.1Level: LLTClassification code 10023476Term: Knee osteoarthritisEUCTR2007-002357-23-GBewcastle Upon Tyne NHS Foundation Trust20
已完成
1 期
A Phase I Clinical Trial comparing Pharmacokinetics of EMD-RX5 Cannabidiol (CBD) capsules to Epidyolex CBD oil in Healthy Volunteers.ACTRN12622000427774Emyria Ltd12